 Connection
Robin Deterding to Lung Diseases, Interstitial
This is a "connection" page, showing publications Robin Deterding has written about Lung Diseases, Interstitial.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
8.113 |
|
|
|
-
Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR, Brown KK, Dumistracel M, Erhardt E, Bertulis J, Gahlemann M, Stowasser S, Griese M. Nintedanib in children and adolescents with fibrosing interstitial lung diseases. Eur Respir J. 2023 02; 61(2).
Score: 0.579
-
Casey A, Deterding R. Childhood Interstitial Lung Disease (chILD): shining a new light on childhood! Thorax. 2022 08; 77(8):742.
Score: 0.545
-
Liptzin DR, Udoko MN, Pinder M, Weinman JP, Galambos C, Deterding RR. Pulmonary interstitial glycogenosis after the first year. Pediatr Pulmonol. 2021 09; 56(9):3056-3058.
Score: 0.520
-
Liptzin DR, Pickett K, Brinton JT, Agarwal A, Fishman MP, Casey A, Towe CT, Taylor JB, Kurland G, Hagood JS, Wambach J, Srivastava R, Al-Saleh H, Dell SD, Young LR, Deterding RR. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities. Ann Am Thorac Soc. 2020 06; 17(6):724-728.
Score: 0.481
-
Deterding RR, Wagner BD, Harris JK, DeBoer EM. Pulmonary Aptamer Signatures in Children's Interstitial and Diffuse Lung Disease. Am J Respir Crit Care Med. 2019 12 15; 200(12):1496-1504.
Score: 0.466
-
Deterding RR, DeBoer EM, Cidon MJ, Robinson TE, Warburton D, Deutsch GH, Young LR. Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019 11 15; 200(10):1219-1227.
Score: 0.464
-
Liptzin DR, Baker CD, Darst JR, Weinman JP, Dishop MK, Galambos C, Brinton JT, Deterding RR. Pulmonary interstitial glycogenosis: Diagnostic evaluation and clinical course. Pediatr Pulmonol. 2018 12; 53(12):1651-1658.
Score: 0.423
-
Mastej EJ, DeBoer EM, Humphries SM, Cook MC, Hunter KS, Liptzin DR, Weinman JP, Deterding RR. Lung and airway shape in neuroendocrine cell hyperplasia of infancy. Pediatr Radiol. 2018 11; 48(12):1745-1754.
Score: 0.421
-
Liptzin DR, Hawkins SMM, Wagner BD, Deterding RR. Sleeping chILD: Neuroendocrine cell hyperplasia of infancy and polysomnography. Pediatr Pulmonol. 2018 07; 53(7):917-920.
Score: 0.418
-
Deterding RR. Children's Interstitial and Diffuse Lung Disease. Progress and Future Horizons. Ann Am Thorac Soc. 2015 Oct; 12(10):1451-7.
Score: 0.348
-
Deterding RR, White CW. Humidifier and environmental "chILD" risks. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):10-2.
Score: 0.309
-
Kerby GS, Wagner BD, Popler J, Hay TC, Kopecky C, Wilcox SL, Quinones RR, Giller RH, Accurso FJ, Deterding RR. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol. 2013 Oct; 48(10):1008-15.
Score: 0.286
-
Popler J, Lesnick B, Dishop MK, Deterding RR. New coding in the International Classification of Diseases, Ninth Revision, for children's interstitial lung disease. Chest. 2012 Sep; 142(3):774-780.
Score: 0.281
-
Prestridge A, Deterding RR. Diffuse lung disease in children. Pediatr Ann. 2010 Dec; 39(12):777-83.
Score: 0.249
-
Popler J, Gower WA, Mogayzel PJ, Nogee LM, Langston C, Wilson AC, Hay TC, Deterding RR. Familial neuroendocrine cell hyperplasia of infancy. Pediatr Pulmonol. 2010 Aug; 45(8):749-55.
Score: 0.243
-
Brody AS, Guillerman RP, Hay TC, Wagner BD, Young LR, Deutsch GH, Fan LL, Deterding RR. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol. 2010 Jan; 194(1):238-44.
Score: 0.234
-
Deterding R. Evaluating infants and children with interstitial lung disease. Semin Respir Crit Care Med. 2007 Jun; 28(3):333-41.
Score: 0.195
-
Deterding R. How to evaluate and treat children's interstitial lung disease. Paediatr Respir Rev. 2006; 7 Suppl 1:S245-7.
Score: 0.183
-
Deterding R, Fan LL. Surfactant dysfunction mutations in children's interstitial lung disease and beyond. Am J Respir Crit Care Med. 2005 Oct 15; 172(8):940-1.
Score: 0.175
-
DeBoer EM, Weinman JP, Ley-Zaporozhan J, Griese M, Deterding R, Lynch DA, Humphries SM, Jacob J. Imaging of pulmonary fibrosis in children: A review, with proposed diagnostic criteria. Pediatr Pulmonol. 2024 Apr; 59(4):845-854.
Score: 0.155
-
Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, Casey A, Krone K, Liptzin DR, O'Connor MG, Kurland G, Taylor JB, Gower WA, Hagood JS, Conrad C, Tam-Williams JB, Fiorino EK, Goldfarb S, Sadreameli SC, Nogee LM, Montgomery G, Hamvas A, Laguna TA, Bansal M, Lew C, Santiago M, Popova A, De A, Chan M, Powers MR, Josephson MB, Camburn D, Voss L, Li Y, Young LR. The US?national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort. Pediatr Pulmonol. 2024 Sep; 59(9):2236-2246.
Score: 0.149
-
Deterding RR, Fan LL, Morton R, Hay TC, Langston C. Persistent tachypnea of infancy (PTI)--a new entity. Pediatr Pulmonol. 2001; Suppl 23:72-3.
Score: 0.125
-
Casey AM, Deterding RR, Young LR, Fishman MP, Fiorino EK, Liptzin DR. Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases. Pediatr Pulmonol. 2020 07; 55(7):1819-1827.
Score: 0.121
-
LeMoine BD, Browne LP, Liptzin DR, Deterding RR, Galambos C, Weinman JP. High-resolution computed tomography findings of thyroid transcription factor 1 deficiency (NKX2-1 mutations). Pediatr Radiol. 2019 06; 49(7):869-875.
Score: 0.111
-
Weinman JP, White CJ, Liptzin DR, Deterding RR, Galambos C, Browne LP. High-resolution CT findings of pulmonary interstitial glycogenosis. Pediatr Radiol. 2018 08; 48(8):1066-1072.
Score: 0.104
-
Houin PR, Deterding RR, Young LR. Exacerbations in neuroendocrine cell hyperplasia of infancy are characterized by increased air trapping. Pediatr Pulmonol. 2016 Mar; 51(3):E9-12.
Score: 0.088
-
Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C, Liptzin DR, Kroehl ME, Deutsch GH, Young LR, Kurland G, Hagood J, Dell S, Trapnell BC, Deterding RR. Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme. Ann Am Thorac Soc. 2015 Oct; 12(10):1498-505.
Score: 0.087
-
Hawkins A, Guttentag SH, Deterding R, Funkhouser WK, Goralski JL, Chatterjee S, Mulugeta S, Beers MF. A non-BRICHOS SFTPC mutant (SP-CI73T) linked to interstitial lung disease promotes a late block in macroautophagy disrupting cellular proteostasis and mitophagy. Am J Physiol Lung Cell Mol Physiol. 2015 Jan 01; 308(1):L33-47.
Score: 0.082
-
Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG, Dell S, Fan LL, Hamvas A, Hilman BC, Langston C, Nogee LM, Redding GJ. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013 Aug 01; 188(3):376-94.
Score: 0.075
-
Hamvas A, Deterding R, Balch WE, Schwartz DA, Albertine KH, Whitsett JA, Cardoso WV, Kotton DN, Kourembanas S, Hagood JS. Diffuse lung disease in children: summary of a scientific conference. Pediatr Pulmonol. 2014 Apr; 49(4):400-9.
Score: 0.074
-
Doan ML, Elidemir O, Dishop MK, Zhang H, Smith EO, Black PG, Deterding RR, Roberts DM, Al-Salmi QA, Fan LL. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism. Thorax. 2009 Aug; 64(8):677-81.
Score: 0.055
-
Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol. 2004 Nov; 38(5):369-78.
Score: 0.041
-
Fan LL, Kozinetz CA, Deterding RR, Brugman SM. Evaluation of a diagnostic approach to pediatric interstitial lung disease. Pediatrics. 1998 Jan; 101(1 Pt 1):82-5.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|